TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsPhase III trials of COVID-19 vaccine start on Tuesday
The trials are expected to finish in half a year at the earliest.
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
I
ndonesian scientists are set to start the phase III clinical trials of a potential COVID-19 vaccine developed by China-based biopharmaceutical company Sinovac Biotech on Tuesday in six different locations in the West Java provincial capital of Bandung.
Padjadjaran University (Unpad) School of Medicine professor Kusnandi Rusmil, who is also the clinical trial research team leader, said the human trials would commence on Aug. 11 although the number of registered volunteers as of Thursday was still half the target.
“So far, about 800 volunteers have registered [for the trials],” Kusnandi said on Thursday.
The tester team was looking for a total of 1,620 volunteers, he said, and that volunteer registrations would be open until Aug. 31.
The six locations chosen for the trials are the Unpad School of Medicine Education Hospital, an Unpad campus, as well as four community health centers (Puskesmas) in Bandung, namely Sukapakir, Garuda, Ciumbuleuit and Dago.
The trials are expected to finish in half a year at the earliest.
Kusnandi said half of the 1,620 volunteers would be injected with the potential vaccine, while the other half would get a placebo. The trial subjects will be divided into the two groups randomly.
